Key components of Pallister's 'made-in-Canada' vaccine sourced from U.S. and Switzerland
When Premier Brian Pallister plunked down a $7.2-million, non-refundable down payment on a yet-to-be approved COVID-19 vaccine from a tiny Calgary pharmaceutical company, he justified the expense as a way of breaking Canada’s dependency on foreign vaccines.
Social Sharing